Search results

117 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
UNC HIV prevention research named scientific breakthrough of the year
The HIV Prevention Trials Network 052 study, led by Myron S. Cohen, MD of the University of North Carolina at Chapel Hill, has been named the 2011 Breakthrough of the Year by the journal Science.
Located in News / 2011 / December
Maternal, infant antiretrovirals prevent breast milk HIV transmission
Each year about 200,000 infants worldwide become infected with HIV through breastfeeding, and in the developing world infant formula is both prohibitively expensive and associated with increased infant deaths.
Located in News / 2010 / June
International AIDS conference features UNC work
New results and next steps are the focus of the year’s most important HIV/AIDS research gathering. UNC researchers present findings on antiretroviral drugs, prevention approaches and community interventions.
Located in News / 2010 / July
Protein changes in immune system determine ability to control HIV without drugs
A small number of people with HIV have the ability to control the infection without drugs. New results from a multinational study involving more than 300 investigators at over 200 institutions around the world may have found a genetic basis to explain how this happens.
Located in News / 2010 / November
A conversation with Dr. Ada Adimora on World AIDS Day
This video is a conversation with UNC epidemiologist Dr. Ada Adimora as she shares her perspective on the impact of HIV infection.
Located in News / 2010 / December
Giving antiretroviral drugs to infants or mothers reduces transmission of HIV through breast milk
Giving daily antiretroviral syrup to breastfeeding infants or treating their HIV-infected mothers with highly active antiretroviral drugs is safe and effective in preventing mother-to-child HIV transmission through breast milk, a study led by University of North Carolina at Chapel Hill investigators has found.
Located in News / 2009 / July
Proof-of-Concept HIV Immunotherapy Study Passes Phase 1 Safety Trial
Julia Sung, MD, assistant professor of medicine in the Division of Infectious Diseases, has proven the safety of a new immunotherapy to re-educate the body’s immune system to better fight HIV infection. The results were recently published in the journal Molecular Therapy.
Located in Vital Signs / 2018 / Sept. 27
UNC receives $1.5 million grant to strengthen HIV/AIDS research training in South Africa
The University of North Carolina at Chapel Hill has received a $1.5 million grant aimed at strengthening HIV/AIDS research training in collaboration with the Wits School of Public Health at the University of the Witwatersrand in Johannesburg, South Africa.
Located in Vital Signs / 2014 / Sept. 18
Strong ties help UNC, Malawi fight disease
UNC researchers began working in Malawi more than 20 years ago. Since then, the relationship has deepened as faculty and students help tackle challenges such as HIV, malaria and a lack of basic health infrastructure. This week, Chancellor Holden Thorp is visiting UNC Project–Malawi to see Carolina’s involvement firsthand and blogging about his trip along the way.
Located in Vital Signs / 2010 / Dec. 16
UNC awarded $1.7 million to curb the spread of HIV in North Carolina
A team of researchers from the Institute for Global Health & Infectious Diseases at UNC has received a $1.7 million grant from the U.S. Centers for Disease Control and Prevention to study novel HIV testing methods to detect acute HIV infection and target sexual networks to curb the spread of HIV in North Carolina.
Located in Vital Signs / 2010 / Vital Signs - June 24, 2010